Evidence map›Paper›PMID 26957310›Full record

ArticleGenome research2016

2C-Cas9: a versatile tool for clonal analysis of gene function.

Vincenzo Di Donato, Flavia De Santis, Thomas O Auer, Noé Testa, Héctor Sánchez-Iranzo, Nadia Mercader, Jean-Paul Concordet, Filippo Del Bene

Abstract read
In one paragraph

Article in Genome research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. eLife · 2026
    Article
  4. Lineage labeling with zebrafish hand2 Cre and CreERT2 recombinase CRISPR knock-ins.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Article
  5. Article
  6. Article
  7. Lineage labeling with zebrafishbioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Article
  10. Synaptic input and CaNature neuroscience · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vincenzo Di DonatoInstitut Curie, PSL Research University, INSERM U 934, CNRS UMR3215, F-75005, Paris, France;
Flavia De SantisInstitut Curie, PSL Research University, INSERM U 934, CNRS UMR3215, F-75005, Paris, France;
Thomas O AuerInstitut Curie, PSL Research University, INSERM U 934, CNRS UMR3215, F-75005, Paris, France;
Noé TestaInstitut Curie, PSL Research University, INSERM U 934, CNRS UMR3215, F-75005, Paris, France;
Héctor Sánchez-IranzoDepartment of Cardiovascular Development and Repair, Atherothrombosis and Imaging, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28028 Madrid, Spain;
Nadia MercaderDepartment of Cardiovascular Development and Repair, Atherothrombosis and Imaging, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28028 Madrid, Spain;
Jean-Paul ConcordetMuséum National d'Histoire Naturelle, INSERM U1154, CNRS UMR 7196, Paris F-75231, France.
Filippo Del BeneInstitut Curie, PSL Research University, INSERM U 934, CNRS UMR3215, F-75005, Paris, France;ORCID 0000-0001-8551-2846

Funding

European Research Council 337703
6 · The paper itself

Abstract

CRISPR/Cas9-mediated targeted mutagenesis allows efficient generation of loss-of-function alleles in zebrafish. To date, this technology has been primarily used to generate genetic knockout animals. Nevertheless, the study of the function of certain loci might require tight spatiotemporal control of gene inactivation. Here, we show that tissue-specific gene disruption can be achieved by driving Cas9 expression with the Gal4/UAS system. Furthermore, by combining the Gal4/UAS and Cre/loxP systems, we establish a versatile tool to genetically label mutant cell clones, enabling their phenotypic analysis. Our technique has the potential to be applied to diverse model organisms, enabling tissue-specific loss-of-function and phenotypic characterization of live and fixed tissues.

Indexed as

CRISPR-Cas SystemsGene SilencingOrganisms, Genetically ModifiedZebrafishAnimals

Identifiers

PMID26957310
PMCPMC4864464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.